Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Mesenchymal stem cells
Phase II clinical trial
Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022
EXO-CD24
Phase II clinical trial
Potential treatment - clinical evidence Experimental Other treatment Jul/13/2022
Bamlanivimab
Phase II clinical trial
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
Etesevimab
Phase II clinical trial
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
Ad26.COV2.S
Phase II clinical trial
Emergency use authorization Experimental Vaccine Jun/22/2022
BNT162b2
Phase II clinical trial
Approved by FDA Experimental Vaccine Jun/22/2022
mRNA-1273
Phase II clinical trial
Emergency use authorization Experimental Vaccine Jun/22/2022
REGEN-COV
Phase II clinical trial
Emergency use authorization Experimental Antiviral Jun/03/2022
Convalescent plasma
Phase II clinical trial
Emergency use authorization Experimental Antiviral May/16/2022
Ivermectin
Phase II clinical trial
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022
ChAdOx1 nCoV-19
Phase II clinical trial
Emergency use authorization Experimental Vaccine Jan/04/2022
BBIBP-CorV
Phase II clinical trial
Potential treatment - clinical evidence Experimental Vaccine Dec/23/2021
Gam-COVID-Vac
Phase II clinical trial
Emergency use authorization Experimental Vaccine Dec/23/2021
Tocilizumab
Phase II clinical trial
Recommended by China's NHC Guidelines Used to treat other disease Other treatment Dec/21/2021
Corticosteroids
Phase II clinical trial
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2021
Favipiravir
Phase II clinical trial
Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021
Chloroquine phosphate
Phase II clinical trial
Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021
Hydroxychloroquine sulfate
Phase II clinical trial
Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021
Enoxaparin
Phase II clinical trial
Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/12/2021
NVX-CoV2373
Phase II clinical trial
Potential treatment - clinical evidence Experimental Vaccine Apr/07/2021